Lung Cancer Therapy
New lung cancer therapy data have been reported by scientists at Mayo Clinic
Published in Hospital Law Weekly, July 10th, 2008
Research findings, 'Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51),' are discussed in a new report. According to a study from the United States, "This study assessed whether maintenance therapy with carboxyaminoimidazole (CAI), compared to placebo, prolonged overall survival in stage IIIB/IV NSCLC patients who had tumor regression or stable disease after treatment with one chemotherapy regimen. After completion of chemotherapy, patients were randomized to receive daily oral CAI at 250mg or placebo."
"Treatment continued until patient...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-07-10)
More Articles from Hospital Law Weekly
- Ballard Spahr Andrews & Ingersoll, LLP
Ballard Acquires Atlanta IP Group - Business of Birth International
Controversies in Childbirth Conference Draws Broad Interest Across Medical Professions, Across the U.S., and Across the Atlantic - Drug Resistance
Federal Action Needed to Fill Antibiotic Pipeline, Says the Alliance for the Prudent Use of Antibiotics - Eric Drew
Credit Card Companies Fueling Healthcare Associated Identity Theft (HAIT) Crimes - Health Insurance
Potential Blues Merger Poses Concern for Area Health Systems - Heart Disease
Appellate Court Rules That $2.7 Million Heart Transplant Verdict Should Stand - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
